Company Filing History:
9 out of 203 
1 out of 12 
1 out of 254 
Years Active: 1979-1987
Title: **Robert D. Elliott: Innovator in Anticancer Compounds**
Introduction
Robert D. Elliott is a noteworthy inventor based in Birmingham, AL, recognized for his contributions to medicinal chemistry. With a prolific portfolio of 11 patents, his work primarily focuses on developing novel compounds with potential anticancer activities.
Latest Patents
Among his most recent patents, Robert has introduced groundbreaking intermediates for preparing 1,2-dihydropyrido[3,4-b]pyrazines, which exhibit significant anticancer properties. These compounds possess a unique structure characterized by several variables, including lower alkyl groups, halogens, and amine substitutions. Additionally, he has developed novel intermediates for pyrido[2,3-d]pyrimidines, further emphasizing his innovative approach to creating effective pharmaceutical agents.
Career Highlights
Throughout his career, Robert has worked with esteemed institutions that include the Southern Research Institute and the Government of the United States of America. His tenure at these organizations underscores his commitment to advancing medical research and innovation.
Collaborations
Robert has collaborated with distinguished coworkers such as Carroll G. Temple, Jr. and John A. Montgomery. These partnerships have played a vital role in fostering an environment of creativity and scientific advancement, which has driven numerous successful projects.
Conclusion
In summary, Robert D. Elliott's contributions to the field of medicinal chemistry are exemplified by his numerous patents and his dedication to developing innovative solutions for cancer treatment. His work not only reflects his ingenuity as an inventor but also his commitment to improving healthcare outcomes.